Cargando…
Immunotherapy for Recurrent Glioma—From Bench to Bedside
SIMPLE SUMMARY: Glioma is the most common and aggressive brain tumor worldwide, and most patients suffer from a recurrence. Additionally, recurrent glioma is often resistant to chemotherapies and radiotherapy. Hence, immunotherapy has come into people’s sights. The most-used immunotherapy is immune...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340154/ https://www.ncbi.nlm.nih.gov/pubmed/37444531 http://dx.doi.org/10.3390/cancers15133421 |